EB Ranking/Comparison

Just wanted to create a post to gauge the strengths of the different EB's (namely EVR/Moelis/PJT/LAZ/PWP/Centerview/GHL).

What are the best groups at each? Where have you seen the banks trending in terms of market share/ability to win big deals etc?

Also, in terms of pay and exit opps at the analyst level, how do these compare and where have analysts typically went?

I know this might have been done before, but wanted to get updated thoughts as I begin to consider some of the opportunities ahead. Thanks in advance for the insight!

 

1st=>2nd yr Analyst from top target here. Here’s how the EBs from your list are perceived from said target, which is a combination of culture, exits, prestige, etc. the smartest kids (who don’t do buyside) go in this tier order. Tiers not ranked within each other

T1: PJT RSSG, EVR (both), Moelis LA T2: CVP, PJT M&A T3: LAZ, Moelis NY, PWP, GHL

Yes you read Laz correctly. Their perception has shrunk for a while and from what I hear continues to fall. That being said all of T3 are stellar and will land you good opps. Your list is also missing a few well regarded boutiques.

edit: once again, the ranking is based on numerous factors and reflects where the smartest kids decide to go. each tier is a level of consideration. does PWP have the same history and recognition that LAZ has? maybe not. but they'll be looked at the same and the quality of kids are around the same.

 

While it is a concern for a few, the 3yr process isn’t a major concern for most. CVP > PJT M&A here

 

Disagree on both. PJT M&A doesn't carry anywhere near close the same reputation as RSSG in my top target. Kids there are good but not top tier.

EVR isn't the same situation as PJT as both M&A and RX consistently get looks from top shops. Lots of my younger peers even weigh RX>M&A due to more technical work and optionality into both distress and PE.

 

Also attended a target but that shouldn’t really matter. Idk why people use that as a line of credibility as if your school gives you distinctly more insight than other non-targets or even other targets.

T1: evr m&a, PJT rx, laz rx, Moelis La T2: evr rx, CVP, PJT m&a, laz m&a T3: PWP, Moelis NY

First, I’m going to put significant weight on firm wide deal flow since that generally tends to increase prestige, lead to better exits and result in worse culture. I would also split Laz in to M&A and RX to give same treatment for EVR and PJT as you did.

Based off that, if you think Evercore RX is really two tiers above LAZ RX, you’re on crack. And if you think PJT M&A is a whole tier better than Laz m&a, you’re still wrong. Laz RX is tier one, I’m not there and I still know they’ve been on a tear. Laz M&A is probably tier 2, lowest pay but makes up for it with strong dealflow and good exits.

You got me good with Greenhill, unranked. As in my greekrank days, Greenhill is upper-mid at best, mixes with good houses but never has and never will break into the top bucket.

Moelis LA is probably the most savage, but analysts there are lights out and it’s in LA so points for originality and spunk.

CVP Is tier one in terms of pay and dealflow. Only thing that relegates them to two is unsupportive exit culture and 3 year analyst program bonus structure. Saw that and was like nope.

If you weighed pay more heavily, then it would prob be PJT, EVR, CVP tier one, but pay really isn’t everything. A lot of bankers don’t go to high finance after their two year stint and Laz still has the best name brand along with EVR outside of finance. An extra 20k a year at CVP means nothing to me if I can’t place at a good PE firm in 3 years and no one outside of finance has heard of this weird regional bank I worked for so they won’t hire me. I can promise you that Lazard doesn’t give two shits if it’s recruiting class is only 90% as talented as it used to be because 95% of those analysts leave the firm after two years anyway.

 

“An extra 20k a year at CVP means nothing to me if I can't place at a good PE firm in 3 years and no one outside of finance has heard of this weird regional bank I worked for so they won't hire me.”

This is just blatant bias. CVP a regional bank is absurd, and while its true they prefer people to stay the three year stint: they don’t claw back the whole bonus, analysts get looks at any and all funds they want, and management is increasingly supportive of recruiting even when people leave early. And those that wait until 2nd year to recruit get lots of support.

 

I disagree with CVP placement. Based on unrivaled pay, excellent culture, and ridiculous deal flow it is clearly a tier one place to be a banker.

People always bring up the 3-yr program as this huge deal breaker and claim exits aren’t as strong but I call bs on that as well. All the analysts I know from there that didn’t end up at MF/UMM PE was purely self-selection. Why go work worse hours for less pay and basically work banking 2.0?

Some still went MF but a lot went HF/Family Office instead, VC, Growth Equity, and even startups. But, everyone that wanted one got a look at pretty much any firm.

With such early recruiting, more and more are waiting to recruit until 2nd year anyways.

 

Would largely agree with this, feel like from a pure prestige standpoint highly accurate for Wharton at least.

 

They're a boutique, not an elite boutique. They only do tech. Similar to why Qatalyst isn't on here and they're arguably the highest paying IB there is at the junior level. Elite boutique doesn't necessarily mean that they're better than the boutiques at everything but that they specialize in general M&A advisory on mandates where they would be competing against BBs.

 

Picture this -- it's 7 years from now -- you've long burned out of banking and work in corporate development at a mid-sized startup.

You find yourself on a Hinge date with a hot french chick. You tell her you used to be an investment banker at Lazard Frères & Company.. oh wait.. or was it someplace called PJT.

..At least that's how I made my decision you nerds.

 
Controversial

I always find these things kind of silly but I'll bite, why not.

Tier 1: PJT RSSG, Laz RX, EVR M&A , HL RX, Centerview M&A Tier 2: PJT M&A, Laz M&A, EVR RX Tier 3: Moelis, PWP, Greenhill

FWIW Lazard bumped up their bonuses by $20k this year. They were 45/55/65/75 and now are 65/75/85/95 (with a 85k base, 10k signing). Which means if you are bottom bucket still make $150k. Something to keep in mind since Lazard isn't the "lowest paying boutique" anymore and now more on par with the other boutiques

 

I almost never comment on WSO but Greenhill definitely isn't an EB

 
Most Helpful

I'm sorry but I just disagree with this list. Here's my list based on pay, exits, culture, and prestige (ordered within tiers):

Tier 1: PJT RSSG, EVR M&A (now places into groups, much larger class size), PJT M&A (been killing it this year, small class size, etc), Moelis LA (stellar shop but harder to get to NYC funds)

Tier 2: Centerview M&A (3-year commitment), EVR RX, HL RX.

Tier 3: Laz RX, Laz M&A (been going downhill lately, small deal size), Moelis NY, PWP

Tier 4: Roth (probs tier 1 or 2 in EMEA), HL, Greenhill, anyone I'm forgetting?

I have also based these rankings on the 1H 2019 M&A tables as I find them to be a good indicator of progress and caliber.

 

Not sure what the argument for PJT M&A above EVR RX and HL RX (or in tier 1 at all) is here — both groups place lights out into both HFs and MF PE/SS and have class sizes around 10 in NYC. I think most people with any knowledge of RX put EVR and HL right up there with PJT RSSG. Know several people at my top target and others who have chosen RX at these firms over EVR M&A and certainly PJT M&A as well.

 

Again, I included pay and prestige. RX is a very specialized field which only very few go into. The pay at HL is def not on par with PJT/EVR and neither is their prestige. I must admit I am not too familiar with Evr's Rx practice, so you might have a point, but I def don't hear about it as much as PJT's. It seems like you have a personal vendetta against PJT M&A or something since you seem to cling onto that group and put them down, but a quick search will show you EVR and PJT were the only EBs in the top 10 global advisors list and EVR is about x2.5 larger than PJT. PJT M&A also did AbbVie Allergan and T-Mobile Sprint. I really don't understand your reasoning.

 

Seems as though this comment was SB’ed 20 times in less than an hour — just your typical Thursday night activity spike on WSO

 

A much stronger group has some of the best opps and deals, only issue is that geographically they are at a disadvantage for NYC recruiting (mind you they still manage to land them).

 

Moelis LA is good, but not tier 1 good. Agree that EVR M&A is tier 1, even with booming class sizes. You are right that PJT M&A has done well this year but (historically) they haven't landed as many mega deals as EVR/Laz/CVP, so not sure if tier 1 is justified. Also you have EVR RX above Laz RX? I question that, Lazard is much more established and wins a lot more mandates.

 

Yep I agree with your comment, but again, the whole point of this ranking is to give a snapshot in time imo... so I base my ranking off of most recent data (pay, exits, deals, reviews etc). It is true that Laz Rx might be a bit more established but due to their brand not being as strong anymore Evercore's brand makes up for the marginal difference in Rx in my view. I agree that judging solely by M&A league tables is wrong, but the fact that only EVR and PJT made it to top 10 advisors really does tell you something.

 

I don’t have a lot to say here - all of these places are good places to work. You have some forum vendetta against a few firms and others seems to be hyped more than they should

Just to give a data point based on company websites YTD

Guggenheim:

deals: 23

Largest deal: 47b

deals above 1bn: 8

Centerview

deals: 42

Largest deal: 50bn

deals above 1bn: 23

Greenhill

deals: 43

Largest deal: 25bn

deals above 1bn: 8

PWP

deals: 39

Largest deal: 8bn

deals above 1bn: 9

Moelis

deals: 78

Largest deal: 5.1

deals above 1bn: 12

Evercore

deals: 111

Largest deal: 90 Ben

deals above 1bn: 24

Lazard

deals: 175

Largest deal: 48bn

deals above 1bn: 53

I don’t have number of bankers but based on this I would say the top EB’s are Laz, Evr and CVP as they consistently take business from the BB’s in high volume

Based on deal flow and exposure I think it would be hard to really distinguish between pwp, ghl, Guggenheim and Moelis with Moelis seemingly being on more, but smaller deals and Guggenheim in fewer but more huge mandates.

No numbers from PJT so I will not comment

 

For analyst exits, it is definitely true that Lazard has lost its standing with respect to PJT and arguably EVC. However, you have to think more holistically than that. Lazard (far more so than any of the other EB's) is cluttered with absurdly powerful people in one way or another. Type of place you walk into the elevator and notice you're sharing a ride with Al Sharpton and Felix Rohatyn. The people at the top have bigger things to worry about than what their analysts who will indefinitely leave after fulfilling two years get paid, exit, experience, etc... This does make for somewhat of a difficult and often insincere environment, but if you realize the incredible presence of the organization you're working for (although will most likely never understand the broader issues Lazard / affiliates work on) it's pretty fascinating. To be less long winded - powerful people respect it immensely. That's not because they used to be a better bank (as some people are mentioning on here), but because they are an organization filled with employees, clients, and advisors with enormous amounts of power. (Tried super hard not to sound like someone with an economic interest in The Last Tycoons and promoting it with cheesy clichés...)

"Rage, rage against the dying of the light."
 

Nihil impedit sint ex. Rerum impedit aut velit ea nostrum accusantium non. In natus ipsam sunt magnam mollitia eos. Fugiat et cum minima iure sit perspiciatis ullam. Aut autem nulla architecto in distinctio aut. Occaecati asperiores soluta quasi laboriosam. Ut blanditiis corrupti maiores aut excepturi odio.

Explicabo perspiciatis corporis facere facilis et quisquam. Qui illo et aut cum iste optio quam. Corporis nobis quia odit debitis tempora natus asperiores. Sint eum ut a nesciunt vel.

Voluptatibus quo maiores quod sit non beatae ipsum id. Alias recusandae reiciendis rerum cumque cumque. Commodi autem molestiae sed voluptas illo est. Non adipisci aut doloremque quis suscipit.

Career Advancement Opportunities

March 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. (++) 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

March 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

March 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

March 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (85) $262
  • 3rd+ Year Analyst (13) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (65) $168
  • 1st Year Analyst (198) $159
  • Intern/Summer Analyst (143) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
Betsy Massar's picture
Betsy Massar
99.0
4
kanon's picture
kanon
98.9
5
Secyh62's picture
Secyh62
98.9
6
dosk17's picture
dosk17
98.9
7
CompBanker's picture
CompBanker
98.9
8
GameTheory's picture
GameTheory
98.9
9
bolo up's picture
bolo up
98.8
10
DrApeman's picture
DrApeman
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”